• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤坏死因子刺激慢性肾脏病和非肾脏炎症中的成纤维细胞生长因子 23 水平。

Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation.

机构信息

Institute of Physiology, University of Zurich, Zurich, Switzerland; Swiss National Center of Competence in Research NCCR-Kidney.CH, University of Zurich, Zurich, Switzerland; Department of Pediatrics, Division of Nephrology, University of California, San Francisco, San Francisco, California, USA.

Institute of Physiology, University of Zurich, Zurich, Switzerland; Swiss National Center of Competence in Research NCCR-Kidney.CH, University of Zurich, Zurich, Switzerland.

出版信息

Kidney Int. 2019 Oct;96(4):890-905. doi: 10.1016/j.kint.2019.04.009. Epub 2019 May 14.

DOI:10.1016/j.kint.2019.04.009
PMID:31301888
Abstract

Fibroblast growth factor 23 (FGF23) regulates phosphate homeostasis, and its early rise in patients with chronic kidney disease is independently associated with all-cause mortality. Since inflammation is characteristic of chronic kidney disease and associates with increased plasma FGF23 we examined whether inflammation directly stimulates FGF23. In a population-based cohort, plasma tumor necrosis factor (TNF) was the only inflammatory cytokine that independently and positively correlated with plasma FGF23. Mouse models of chronic kidney disease showed signs of renal inflammation, renal FGF23 expression and elevated systemic FGF23 levels. Renal FGF23 expression coincided with expression of the orphan nuclear receptor Nurr1 regulating FGF23 in other organs. Antibody-mediated neutralization of TNF normalized plasma FGF23 and suppressed ectopic renal Fgf23 expression. Conversely, TNF administration to control mice increased plasma FGF23 without altering plasma phosphate. Moreover, in Il10-deficient mice with inflammatory bowel disease and normal kidney function, plasma FGF23 was elevated and normalized upon TNF neutralization. Thus, the inflammatory cytokine TNF contributes to elevated systemic FGF23 levels and also triggers ectopic renal Fgf23 expression in animal models of chronic kidney disease.

摘要

成纤维细胞生长因子 23(FGF23)调节磷酸盐稳态,其在慢性肾脏病患者中的早期升高与全因死亡率独立相关。由于炎症是慢性肾脏病的特征,并与血浆 FGF23 增加相关,我们研究了炎症是否直接刺激 FGF23。在一项基于人群的队列研究中,血浆肿瘤坏死因子(TNF)是唯一与血浆 FGF23 独立且呈正相关的炎症细胞因子。慢性肾脏病的小鼠模型显示出肾脏炎症、肾脏 FGF23 表达和全身 FGF23 水平升高的迹象。肾脏 FGF23 的表达与调节其他器官 FGF23 的孤儿核受体 Nurr1 的表达相吻合。TNF 的抗体中和作用使血浆 FGF23 正常化并抑制异位肾脏 Fgf23 表达。相反,给予对照小鼠 TNF 可增加血浆 FGF23,而不改变血浆磷酸盐。此外,在具有炎症性肠病和正常肾功能的 Il10 缺陷型小鼠中,血浆 FGF23 升高,并在 TNF 中和后恢复正常。因此,炎症细胞因子 TNF 导致全身性 FGF23 水平升高,并在慢性肾脏病的动物模型中触发异位肾脏 Fgf23 表达。

相似文献

1
Tumor necrosis factor stimulates fibroblast growth factor 23 levels in chronic kidney disease and non-renal inflammation.肿瘤坏死因子刺激慢性肾脏病和非肾脏炎症中的成纤维细胞生长因子 23 水平。
Kidney Int. 2019 Oct;96(4):890-905. doi: 10.1016/j.kint.2019.04.009. Epub 2019 May 14.
2
Interleukin-6 contributes to the increase in fibroblast growth factor 23 expression in acute and chronic kidney disease.白细胞介素-6 有助于增加急性和慢性肾脏病中成纤维细胞生长因子 23 的表达。
Kidney Int. 2018 Aug;94(2):315-325. doi: 10.1016/j.kint.2018.02.026. Epub 2018 May 31.
3
FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease.成纤维细胞生长因子 23 作为慢性肾脏病相关外周动脉疾病的潜在病理生理因素。
Int J Mol Sci. 2024 May 17;25(10):5457. doi: 10.3390/ijms25105457.
4
Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.炎症和成纤维细胞生长因子23水平升高是慢性肾脏病患者死亡的独立危险因素。
Kidney Int. 2017 Mar;91(3):711-719. doi: 10.1016/j.kint.2016.10.021. Epub 2016 Dec 22.
5
A comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model.一项比较转录组分析鉴定了在小鼠 CKD 模型肾脏中受 FGF23 调控的基因。
PLoS One. 2012;7(9):e44161. doi: 10.1371/journal.pone.0044161. Epub 2012 Sep 6.
6
Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease.慢性肾脏病小鼠模型中 FGF23 变化及矿物质代谢异常的纵向评估。
J Bone Miner Res. 2012 Jan;27(1):38-46. doi: 10.1002/jbmr.516.
7
Associations of Fibroblast Growth Factor 23 with Markers of Inflammation and Leukocyte Transmigration in Chronic Kidney Disease.成纤维细胞生长因子23与慢性肾脏病炎症标志物及白细胞迁移的相关性
Nephron. 2018;138(4):287-295. doi: 10.1159/000485472. Epub 2018 Jan 4.
8
Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease.成纤维细胞生长因子23直接作用于肝细胞以促进慢性肾脏病中的炎症反应。
Kidney Int. 2016 Nov;90(5):985-996. doi: 10.1016/j.kint.2016.05.019. Epub 2016 Jul 22.
9
The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk.无肾脏疾病的循环成纤维细胞生长因子 23 升高不会增加心血管疾病风险。
Kidney Int. 2018 Jul;94(1):49-59. doi: 10.1016/j.kint.2018.02.017. Epub 2018 May 5.
10
Effects of erythropoietin on fibroblast growth factor 23 in mice and humans.促红细胞生成素对小鼠和人类成纤维细胞生长因子 23 的影响。
Nephrol Dial Transplant. 2019 Dec 1;34(12):2057-2065. doi: 10.1093/ndt/gfy189.

引用本文的文献

1
New and Emerging Biomarkers in Chronic Kidney Disease.慢性肾脏病中的新型和新兴生物标志物
Biomedicines. 2025 Jun 10;13(6):1423. doi: 10.3390/biomedicines13061423.
2
Impact of online hemodiafiltration on bone turnover in children with CKD-5d: A prospective cohort study.在线血液透析滤过对CKD-5d儿童骨转换的影响:一项前瞻性队列研究。
Pediatr Nephrol. 2025 May 19. doi: 10.1007/s00467-025-06805-2.
3
The association between anti-inflammatory therapies and renal outcomes in patients with established cardiovascular disease or high cardiovascular risks: a meta-analysis of randomised controlled trials.
抗炎治疗与已确诊心血管疾病或心血管风险高的患者肾脏结局之间的关联:一项随机对照试验的荟萃分析。
Inflammopharmacology. 2025 May;33(5):2711-2720. doi: 10.1007/s10787-025-01711-3. Epub 2025 Mar 19.
4
The vitamin D hormone, 1,25(OH)D, regulates fibroblast growth factor 23 (FGF23) production in human skin cells.维生素D激素1,25(OH)D可调节人类皮肤细胞中成纤维细胞生长因子23(FGF23)的生成。
Am J Physiol Cell Physiol. 2025 Apr 1;328(4):C1177-C1192. doi: 10.1152/ajpcell.00827.2024. Epub 2025 Mar 7.
5
FGF-based drug discovery: advances and challenges.基于成纤维细胞生长因子(FGF)的药物研发:进展与挑战
Nat Rev Drug Discov. 2025 May;24(5):335-357. doi: 10.1038/s41573-024-01125-w. Epub 2025 Jan 28.
6
Establishment of epithelial inflammatory injury model using adult kidney organoids.利用成人肾脏类器官建立上皮炎症损伤模型。
Life Med. 2024 May 9;3(3):lnae022. doi: 10.1093/lifemedi/lnae022. eCollection 2024 Jun.
7
Severe hypophosphatemia induced by excessive production of FGF23 in acute hepatitis: from bedside to bench.急性肝炎中FGF23过度产生所致的严重低磷血症:从床边到实验室
Clin Kidney J. 2024 Oct 9;17(11):sfae307. doi: 10.1093/ckj/sfae307. eCollection 2024 Nov.
8
Fibroblast growth-factor 23-Klotho axis is associated with systemic inflammation and myokine profile in children with chronic kidney disease.成纤维细胞生长因子23-klotho轴与慢性肾脏病患儿的全身炎症和肌动蛋白谱相关。
Hormones (Athens). 2024 Sep;23(3):517-526. doi: 10.1007/s42000-024-00586-3. Epub 2024 Aug 7.
9
FGF23 as a Potential Pathophysiological Factor in Peripheral Arterial Disease Associated with Chronic Kidney Disease.成纤维细胞生长因子 23 作为慢性肾脏病相关外周动脉疾病的潜在病理生理因素。
Int J Mol Sci. 2024 May 17;25(10):5457. doi: 10.3390/ijms25105457.
10
Mechanisms of inflammation modulation by different immune cells in hypertensive nephropathy.不同免疫细胞在高血压肾病中炎症调节的机制。
Front Immunol. 2024 Mar 13;15:1333170. doi: 10.3389/fimmu.2024.1333170. eCollection 2024.